Birgit Koch

Title: Birgit Koch: Innovator in Biomedical Research

Introduction

Birgit Koch is a prominent inventor based in Amsdorf, Germany. She has made significant contributions to the field of biomedical research, particularly in the development of innovative solutions for treating diseases related to the QPCTL gene. With a total of 3 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Birgit Koch's latest patents include groundbreaking research on mouse models carrying a knock-out mutation of the QPCTL gene. This invention focuses on a non-human animal model, specifically a mouse, that carries a QPCTL knock-out mutation. The patent also discloses respective cells and cell lines, along with methods and compositions for evaluating agents that affect QPCTL, aimed at treating QPCTL-related diseases. Another notable patent involves the crystal structure of glutaminyl cyclase, which presents novel crystal structures of both human and murine glutaminyl cyclase. This patent outlines methods for preparing the crystals and their use in identifying inhibitors of glutaminyl cyclase.

Career Highlights

Birgit Koch is associated with Probiodrug AG, where she continues to advance her research and innovations. Her work has been instrumental in understanding the implications of the QPCTL gene in various diseases, paving the way for potential therapeutic applications.

Collaborations

Birgit has collaborated with esteemed colleagues such as Stephan Schilling and Jens-Ulrich Rahfeld, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Birgit Koch's contributions to biomedical research exemplify the impact of innovative thinking in addressing complex health challenges. Her patents reflect a commitment to advancing scientific knowledge and improving treatment options for patients.